Yoseph Shaaltiel
2017
In 2017, Yoseph Shaaltiel earned a total compensation of $472.7K as Executive Vice President, Research and Development at Protalix BioTherapeutics, a 2% increase compared to previous year.
Compensation breakdown
| Bonus | $62,176 |
|---|---|
| Option Awards | $41,454 |
| Salary | $288,326 |
| Other | $80,786 |
| Total | $472,742 |
Shaaltiel received $288.3K in salary, accounting for 61% of the total pay in 2017.
Shaaltiel also received $62.2K in bonus, $41.5K in option awards and $80.8K in other compensation.
Rankings
In 2017, Yoseph Shaaltiel's compensation ranked 12,059th out of 14,666 executives tracked by ExecPay. In other words, Shaaltiel earned more than 17.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 12,059 out of 14,666 | 18th |
Division Manufacturing | 4,748 out of 5,770 | 18th |
Major group Chemicals And Allied Products | 1,729 out of 2,074 | 17th |
Industry group Drugs | 1,432 out of 1,730 | 17th |
Industry Biological Products, Except Diagnostic Substances | 260 out of 316 | 18th |
Source: SEC filing on March 6, 2018.
Shaaltiel's colleagues
We found four more compensation records of executives who worked with Yoseph Shaaltiel at Protalix BioTherapeutics in 2017.